维普中文期刊产品整合服务
41篇 您的检索式:作者名="ARCHIMBAUD E"
    题名 作者 年代 出处 被引量
1A randomized,double-blind,placebo controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia显示文摘 OTTMANN OG LIU-YAN JA 1999Blood1999,94,:1
2CD34 expression is associated with major adverse prognostic factors in adult acute lymphohlastic leukemia显示文摘Thomas X Archimbaud E Charrin C 1995Leukemia1995,9,2:1
3Efficacy of 3,4,3-LIHOPO for reducing the retention of uranium in rat after acute administration显示文摘Henge-Napoli MH Archimbaud M Ansoborlo E et a1 1995Int Radiat Biol1995,68,4:1
4Acute myelogenous leukemia显示文摘PINTO A ZULIAN CB ARCHIMBAUD E 2004Cfite Bey Oncol Hematol2004,14,:1
5A randomized phase Ⅱ study on the effects of 5-aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia:an EIRTE Leukemia Cooperative group phase Ⅱ study显示文摘Willemze R Suciu S Archimbaud E 1997Leukemia1997,11,1:1
6CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia 显示文摘Thomas X Archimbaud E Charrin C 1995Leukemia1995,9,2:1
7Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis 显示文摘CAMPOS L GUYOTAT D ARCHIMBAUD E 1992Blood1992,799,2:1
8Multicerter randomized plase Ⅱ trial of, darabicin, vsmitoxantrone combined with VP16 and cytarabine for Induction/consolidation theapy, fallowed a feasibility study of antolo-gous peripheral blood stem cell transp lantation in elderly patientswith acute myeloid显示文摘ARCHIMBAUD E JEHN U THOMAS X 1999Leukemia1999,13,:1
9Clinical significance of multidrug resistance P-glycoprotein expression on acute nanlymphoblastic leukemia cell at diagnosis显示文摘Campos L Gugotat D Archimbaud E 1992Blood1992,79,:1
10Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis显示文摘Campos L Guyotat D Archimbaud E 1992Blood1992,79,2:1
11A randomized phase II study on the effects of 5-Aza-2′ -deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study 显示文摘Willemze R Suciu S Archimbaud E 1997Leukemia1997,11,1:1
12Multicenter randomizedplase II trail of darablcin VS mitoxantrone combined with VP - 16and cytarabine for induction/consolidation theapy,fallowed a feasi-bility study of autologous peripheral blood stem cell transplantationin elderly patients with acute myeloid 显示文摘Archimbaud E Jehn U Thomas X 1999Leukemia1999,13,6:1
13Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis显示文摘CAMPOS L GUYOTAT D ARCHIMBAUD E 1992Blood1992,79,2:1
14Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis显示文摘Campos L Guyotat D Archimbaud E 1992Blood1992,79,:1
15A randomized phase E study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine oridarubiein in patients with relapsed acute leukemia:An EORTC leukemia cooperative group phase E study (06893) 显示文摘Willemze R Sueiu S Archimbaud E 1997Leukemia1997,11,11:1
16A randomized comparison of all transretinoic acid(ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia显示文摘Fenaux P Chastang C Chevret S Sane M Dombret H Archimbaud E 1999Blood1999,94,4:1
17Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly:confirmation of the exsteuce of diffent entities with 11q23 breakpoint leukemia 显示文摘Archimbaud E Charrin C Magaud J P et at 1998Leukemia1998,12,:1
18CD34 expression is associated with major adverse prognostic factors in adult Lymphoblastic Leukemia 显示文摘Thomas X Archimbaud E charrin C 1995Leukemia1995,9,4:1
19A randomized phase Ⅱ study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Co operative Group phase Ⅱ study (06893)显示文摘Willemze R Suciu S Archimbaud E 1997Leukemia1997,11,1:1
20Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission:a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen:a report from the Group d'Etudes de la Greffe de Moelle Osseuse显示文摘Blaise D Maraninchi D Archimbaud E 1992Blood1992,79,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费